Pacira Pharmaceuticals Stock Performance
as on October 24, 2026 at 6:27 am IST
Day's Low
$36.34$36.37
0.08%
Downside
52 Week's Low
52 Week's High
$18.80$36.6748.31%
Downside
0.81%
Upside
Pacira Pharmaceuticals share price movements today
- Previous Close
- $36.34
- Open
- $36.37
- Volume
- 375.5K
- Market Cap
- $1.5B
- Day's Low - High
- $36.34 - $36.37
- 52 Week Low - High
- $18.80 - $36.67
Pacira Pharmaceuticals Historical Returns
- 1 Month Return
- + 47.54 %
- 3 Month Return
- + 40.15 %
- 1 Year Return
- + 67.77 %
- 3 Year Return
- + 29.74 %
- 5 Year Return
- -30.93 %
Pacira Pharmaceuticals Stock Fundamentals & Key Indicators
Check Pacira Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.5B
EPS (TTM)
0.3521
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.30%
PE Ratio (TTM)
103.18
Industry PE ratio
1.29
PEG Ratio
1.59
EBITDA
114.8M
Revenue (TTM)
746.2M
Profit Margin
79.21%
Return On Equity TTM
2.13%
Pacira Pharmaceuticals vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Pacira Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Neutral | $1.5B | -30.93% | 103.18 | 79.21% | 0.00% | |
| Buy | $41.2B | NA | 63.90 | 47.54% | 1.08% | |
| StrongBuy | $24.2B | 206.16% | 18.64 | 86.14% | 0.00% | |
| Buy | $21.4B | 32.57% | -51.25 | 34.83% | 2.60% | |
| Buy | $44.3B | NA | 20.54 | 65.57% | 1.98% |
Stock Returns calculator for Pacira Pharmaceuticals Stock including INR - Dollar returns
The Pacira Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Pacira Pharmaceuticals investment value today
Current value as on today
₹1,81,612
Returns
₹81,612
(+81.61%)
Returns from Pacira Pharmaceuticals Stock
₹67,913 (+67.91%)
Dollar Impact
₹13,698 (+13.7%)
Analyst Recommendation on Pacira Pharmaceuticals Stock
Based on 5 analysts
0.00%
Buy
100.00%
Hold
0.00%
Sell
Based on 5 analysts, 100% of analysts recommend a 'HOLD' rating for Pacira Pharmaceuticals. Average target price of $33.57
Pacira Pharmaceuticals Share Price Target
Get share price movements and forecasts by analysts on Pacira Pharmaceuticals.
What analysts predicted
-8.34%DOWNSIDE
Target Price
$33.57
Current Price
$36.37
Analyzed by
5 Analysts
High
$36.5
Target
$33.57
Low
$36
Pacira Pharmaceuticals target price $33.57, a slight downside of -8.34% compared to current price of $36.37. According to 5 analysts rating.
Indian Investors' Interest in Pacira Pharmaceuticals Stock
Search interest for Pacira Pharmaceuticals Stock has increased by 979% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:979% versus previous 30 day period
Pacira Pharmaceuticals Quarterly Profit & Loss
All numbers in Millions USD
Pacira Pharmaceuticals Annual Profit & Loss
All numbers in Millions USD
Pacira Pharmaceuticals Quarterly Cash Flow
All numbers in Millions USD
Pacira Pharmaceuticals Annual Cash Flow
All numbers in Millions USD
Pacira Pharmaceuticals News & Key Events
Today's Timeline - 09 October
Fri, 07:07 PM
-Viatris agrees to acquire Pacira BioSciences for $1.65 billion, adding high-margin medicines Exparel and Zilretta to its portfolio.
Insights on Pacira Pharmaceuticals
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 177.37M → 192.39M (in $), with an average increase of 7.8% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 1.63M → 4.65M (in $), with an average increase of 40.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, PCRX stock has moved up by 47.5%
NO EFFECTAgainst Peers
In the last 1 year, Viatris Inc. Common Stock has given 79.2% return, outperforming this stock by 11.4%
- NO EFFECT
Against Peers
In the last 3 years, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 107.2% return, outperforming this stock by 77.5%
About Pacira Pharmaceuticals
| Organisation | Pacira Pharmaceuticals |
| Headquarters | 2000 Sierra Point Parkway, Brisbane, CA, 94005, US |
| Industry | Drug Manufacturers - Specialty & Generic |
| CEO | Frank D. Lee |
Key Management of Pacira Pharmaceuticals
Name | Title |
|---|---|
Dr. Jonathan Slonin M.D. | Chief Medical Officer |
Ms. Lauren Bullaro Riker | Principal Accounting Officer & Senior VP of Finance |
Mr. Anthony Molloy III, Esq. | Chief Legal & Compliance Officer |
Mr. Christopher C. Young | Chief Manufacturing Officer |
Mr. Frank D. Lee | CEO & Director |
Mr. Shawn M. Cross | Chief Financial Officer |
Ms. Kristen Williams Esq., J.D. | Chief Administrative Officer & Secretary |
Mr. Brendan P. Teehan | Chief Commercial Officer |
Ms. Susan Mesco | Head of Investor Relations |
Ms. Krys Corbett Esq. | Chief Business Officer |
FAQs
What is Pacira Pharmaceuticals share price today?
Pacira Pharmaceuticals share price today is $36.37 as on . Pacira Pharmaceuticals share today touched a day high of $36.37 and a low of $36.34.
What is the 52 week high and 52 week low for Pacira Pharmaceuticals share?
Pacira Pharmaceuticals share touched a 52 week high of $36.67 on and a 52 week low of $18.80 on . Pacira Pharmaceuticals stock price today i.e. is trending at $36.37,which is 0.80% down from its 52 week high and 93.46% up from its 52 week low.
What is Pacira Pharmaceuticals's market capitalisation today?
Pacira Pharmaceuticals market capitalisation is $0.00T as on .
How to invest in Pacira Pharmaceuticals Stock (PCRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Pacira Pharmaceuticals on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Pacira Pharmaceuticals Stock (PCRX) from India?
Indian investors can start investing in Pacira Pharmaceuticals (PCRX) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Pacira Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pacira Pharmaceuticals share’s latest price of $36.37 as on October 24, 2026 at 12:57 am IST, you will get 0.2750 shares of Pacira Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Pacira Pharmaceuticals has given to Indian investors in the last 5 years?
Pacira Pharmaceuticals stock has given -30.93% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?